<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03494023</url>
  </required_header>
  <id_info>
    <org_study_id>Col-gastro 7</org_study_id>
    <nct_id>NCT03494023</nct_id>
  </id_info>
  <brief_title>EUS Evaluation of CBD Diameter in Malignant Obstructive Jaundice</brief_title>
  <acronym>ECCO</acronym>
  <official_title>Endoscopic Ultrasound Evaluation of the Common Bile Duct in Patients With Obstructive Jaundice Due to Bilio-Pancreatic Malignancies: A Multicenter Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Hospital Colentina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Catholic University, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinical Hospital Colentina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the study is to evaluate the size of the common bile duct (CBD) in a&#xD;
      large cohort of patients with jaundice secondary to pancreatic head or distal bile duct&#xD;
      malignancy undergoing diagnostic EUS for tissue acquisition or evaluation of resectability&#xD;
      and to establish factors associated with a dilation of the CBD greater than 15mm.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale: The size of the common bile duct (CBD) may influence the type of stent used and&#xD;
      the type of the procedure performed in cases of EUS-guided biliary drainage. However, no data&#xD;
      of the size of the CBD in patients with jaundice presenting with a pancreatic head mass or&#xD;
      with a distal cholangiocarcinoma/ carcinoma of the ampulla of Vater are available.&#xD;
&#xD;
      Objectives: To evaluate the size of the CBD in a large cohort of patients with jaundice&#xD;
      secondary to pancreatic head or distal bile duct malignancy undergoing diagnostic EUS for&#xD;
      tissue acquisition or evaluation of resectability and to establish factors associated with a&#xD;
      dilation of the CBD greater than 15mm.&#xD;
&#xD;
      Study design: International prospective observational multicenter trial. Study population:&#xD;
      Patients ≥18 years old, referred for EUS-guided tissue sampling or evaluation of&#xD;
      resectability of a pancreatic, a distal bile duct lesion or a carcinoma of the ampulla of&#xD;
      Vater determining obstructive jaundice.&#xD;
&#xD;
      Intervention: EUS examination Main study parameters/endpoints: measurement of the CBD in&#xD;
      patients with an obstructive distal biliary mass. Determine the factors associated with a CBD&#xD;
      greater than 15mm Nature and extent of the burden and risks associated with participation,&#xD;
      benefit and group relatedness: Measurement of the CBD during EUS examination does not add&#xD;
      additional risks to the procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 27, 2018</start_date>
  <completion_date type="Actual">April 15, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Common bile duct diameter</measure>
    <time_frame>Enrollment over 6 months</time_frame>
    <description>Measurement by endoscopic ultrasound in patients with malignant obstructive jaundice</description>
  </primary_outcome>
  <enrollment type="Actual">539</enrollment>
  <condition>Pancreatic Cancer</condition>
  <condition>Cholangiocarcinoma of the Extrahepatic Bile Duct</condition>
  <condition>Ampulla of Vater Cancer</condition>
  <condition>Jaundice, Obstructive</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Endoscopic ultrasound</intervention_name>
    <description>Measurement of the common bile duct diameter</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This study concerns individuals with jaundice with an indication for EUS examination of a&#xD;
        pancreatic head solid lesion, a distal CBD mass, or a carcinoma of the ampulla of Vater who&#xD;
        undergo diagnostic EUS-guided tissue acquisition or for evaluation of resectability,&#xD;
        discovered at previously performed imaging studies. Only patients with a definitive&#xD;
        diagnosis of neoplasia will enter in the final analysis. Eligible individuals will be&#xD;
        recruited by endosonographers among the centers of the ECCO study group.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with jaundice and a pancreatic head mass lesion referred for EUS-guided&#xD;
             tissue acquisition or staging&#xD;
&#xD;
          -  Patients with jaundice and a distal CBD lesion suggestive of cholangiocarcinoma or a&#xD;
             carcinoma of the ampulla of Vater referred for EUS-guided tissue acquisition or&#xD;
             staging&#xD;
&#xD;
          -  Serum bilirubin level ≥3 mg/dL&#xD;
&#xD;
          -  Age ≥18 years&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of altered anatomy from previous gastric surgery (Billroth II or Roux-en-Y&#xD;
             anastomosis)&#xD;
&#xD;
          -  Previously performed sphincterotomy, biliary plastic stent or metal stent placement&#xD;
&#xD;
          -  Previous percutaneous drainage of the bile duct&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Inability to sign the informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mihai Rimbas, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Hospital Colentina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gastroenterology Department, Clinical Hospital Colentina</name>
      <address>
        <city>Bucharest</city>
        <zip>020125</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 31, 2018</study_first_submitted>
  <study_first_submitted_qc>April 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 11, 2018</study_first_posted>
  <last_update_submitted>April 26, 2020</last_update_submitted>
  <last_update_submitted_qc>April 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinical Hospital Colentina</investigator_affiliation>
    <investigator_full_name>Mihai Rimbas</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholangiocarcinoma</mesh_term>
    <mesh_term>Jaundice</mesh_term>
    <mesh_term>Jaundice, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

